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Evidence that renal and chorionic tissues contain similar nuclear
binding proteins that recognize the human renin promoter
TADASHI KONOSHJTA,1 STEPHANE GERMAIN, JOSEYFE PHILIPPE, PIERRE CORVOL, and FLORENCE PINET
INSERM Unit 36, College de France, Paris, France
Evidence that renal and chorionic tissues contain similar nuclear
binding proteins that recognize the human renin promoter. This study
examines whether the human renal cortex, the major renin producing site,
contains nuclear factors that bind to the human renin proximal promoter.
Footprint analysis of the human renin promoter region showed that
human renal cortex cell nuclear extracts interacted with 6 putative
cis-elements (the Ets domain-protein, a Pit-i like binding site, a CRE
sequence, an ARP-i like binding site, an AGE3 like region, and a
unknown consensus region, designated element C). Transient DNA
transfection studies on chorionic cells implicated the CRE and Pit-i
consensus sites in the regulation of renin gene transcription by cAMP.
Electromobility shift assays showed that renal proteins bind specifically to
these sequences, and that one of them is CREB; two others seem to be
Ets-1 and ARP-1. These results raise the possibility that the human renal
cortex and human chorionic cells have the same trans-acting factors that
bind to the proximal human renin promoter.
The renin-angiotensin system plays a major role in blood
pressure regulation and electrolyte metabolism [1]. The first and
rate limiting step in the production of angiotensin II, the conver-
sion of angiotensinogen to angiotensin I, is catalyzed by the
aspartyl protease, renin (E. C. 3. 4. 23. 15), which is synthesized by
the renal juxtaglomerular (JG) cells. Since there is no established
JG cell line, several cell lines of other origins have been used as
models of renin-producing cells; one of this is human chorionic
cell line [21. We have mapped six protein-binding sites in the
proximal human renin promoter region (—336 to +16) by foot-
print analysis using human chorionic cell nuclear extracts [3].
These footprints all have similar consensus sequences for several
known transcription factors, including the Ets-domain (—291—6)
[4], Pit-i consensus binding site (—797—62) [5], CRE (—234/
—214) [6], ARP-i binding site (—2597—245) [71, AGE3 binding
site (—2937—272) [81 and an unknown consensus region, desig-
nated element C (—1077—83). We have also demonstrated that
the CRE and Pit-i consensus sites are implicated in the regulation
of renin gene transcription by cAMP [9]. Lastly, we have shown
that distinct Pit-i factors are present in chorionic and renal cortex
cells, which both specifically bind to the renin Pit-I-like motif. We
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have now examined the similarity between the transcription
factors from chorionic and renal cells that bind to the human
renin promoter in order to identify the proteins binding to the
cis-acting sites.
Kidney extracts were prepared from ischemic kidneys removed
surgically for their very high renin secretion. The renin-producing
cortex was then carefully dissected from the rest of kidney. Our
results suggest that human renal cortex and chorionic cells have
several trans-acting factors in common that specifically bind to the
human renin promoter region at the same cis-regulatory elements
and are probably involved in regulating the renin gene.
Methods
Preparation of nuclear extracts of human renal cortex
Renal cortex nuclear extracts were prepared essentially accord-
ing to Gorski, Carneiro and Shibler [101. The renal cortex was
carefully dissected from the rest of the kidney. All manipulaions
were carried out at 4°C. Minced kidney (10 to 20 g) was
homogenized in 30 ml modified Schibler homogenization buffer
(SHB) [10 mvt Hepes (pH 7.6), 15 mrvt KCI, 2 msi EDTA, 2.4 M
sucrose, 0.5 mM DTT containing cocktail of inhibitors (0.15 mist
spermine, 0.5 mM spermidine, 0.5 misi PMSF, 2 misi benzamidine,
5 sgIml aprotinin, 5 sg/ml pepstatin, 5 jig/mI leupeptin)] using a
motor-driven Teflon-glass homogenizer. The homogenate was
filtered through four layers of gauze, giving a final volume of 85
ml. This was layered (in three 27 ml aliquots) over three 10 ml
cushion solutions (2 M sucrose, 10% glycerol, 0.5 mist DTT and the
same cocktail of inhibitors described above) in three tubes and
centrifuged for 45 minutes at 24,000 rpm in a SW27 rotor at 0°C.
The nuclear pellets were resuspended in 50 ml SHB/water (9:1
vol/vol). This suspension was layered onto 10 ml cushion solution
and centrifuged as before. Nuclear extracts were prepared from
the pelleted nuclei by the method of Shapiro et a! [111. The
protein concentration was determined according to Lowry et al
[121, and the extracts were stored in liquid nitrogen.
Preparation of extracts from Cos-1 tran,sfected cells
Extracts of Ets-i and ARP-l cells were prepared according to
Kumar and Chambon [13]. Cos-i cells were maintained as stocks
in Dulbecco's modified Eagle's medium supplemented with 10%
fetal calf serum. The cells at 50 to 60% confluence in 225
cm2-flasks were transfected with 63 jig of Ets-i [14] or ARP-1 [15]
eDNA plasmid by calcium phosphate/DNA copreeipitation for
forty hours [16]. The cells were then harvested in 40 mist Tris-HCI
pH 7.4, 1 mist EDTA, 0.15 M NaCI, collected by low speed
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______________________________ _______________
Electromobilily shift assays (EMSAs)
Table I summarizes the sequences of each oligonucleotide used
+2 for EMSA. Double-stranded oligonucleotides were synthesized
(Applied Biosystems) and end-labeled with [y-32P]ATP and T4
polynucleotide kinase.
Binding reactions for Ets-REN, Pit-1-REN, element C and
CRE-REN, was performed by incubating 3 jig human renal cortex
nuclear extract or with I jil Cos-1 cell extract (for Ets-REN) with
20 fmole (about 20,000 cpm) end-labeled double-stranded oligo-
nucleotides for 15 minutes at 4°C in 18 jil buffer containing 10 mivi
Hepes (pH 7.8), 1 mist Na2HPO4 (pH 7.2), 0.1 mist EDTA, 50 mist
KCI, 4 mist MgCI2, 4 mist spermidine, 2.5% glycerol, 0.75-2 jig
double-stranded poly(dl-dC) and 0 to 1 jig sonicated salmon
sperm DNA. The specificity of the DNA/protein binding was
determined by running the same binding reaction using different
competitor oligonucleotides (homologous and heterologous; Ta-
ble 1). The bound and free elements were separated by electro-
phoresis in 6% polyacrylamide gels in 22 mist Tris/borate/0.5 mM
_______________ ___________________
EDTA at 250 volt for two to three hours.
ARP-1-REN, EMSA binding reactions was performed accord-
ing to Ladias et al [151 using 60 ni ARP-1 transfected Cos-1
extract, or 3 jig human renal cortex nuclear extract. These were
incubated with 20 fmole (about 20,000 cpm) labeled oligonucle-
otide for 30 minutes at 4°C in 20 jil buffer containing 25 mM
Hepes (pH 7.6), 8% Ficoll 400, 40 mist KCI, 1 mist DTF, 5 mM
MgCl2, 1 jig of double-stranded poly(dI-dC) with or without
competitor oligonucleotides (Table 1). The components were
separated by electrophoresis in denaturing 4% polyacrylamide
gels run in 44 mist Tris/borate/1 mist EDTA at 10 volts/cm for two
to three hours.
EMSA binding reactions for AGE3-REN [8] were performed
by incubating 3 jig human renal cortex nuclear extract with 20
fmole (about 20,000 cpm) labeled oligonucleotide for 30 minutes
at room temperature in 20 jil buffer [12 mist Hepes (pH 7.9), 60
mM KCI, 0.1 mist EDTA, 0.5 mist DTI, 0.5 mist PMSF, 12%
glycerol and 0.5 jig of double-stranded poly(dI-dC) with or
without competitor oligonucleotides]. The components were sep-
arated by electrophoresis in non-denaturing 5% polyacrylamide
gels run in 88 mist Tris/borate/2 mist EDTA at 140 volts for three
hours.
Western blot analysis
Purified CREB (provided by Dr. G. Schutz, Heidelberg, Ger-
many) and nuclear extracts from human chorionic and kidney
cells were analyzed by SDS-PAGE followed by Western blotting.
SDS-PAGE was carried out on a 7.5% polyacrylamide gel [171.
The clectrophoresed proteins were transferred to a polyvinylidene
difluoride membrane (Immobilon P, Millipore) and the mem-
brane was incubated for one hour in 50 mist Tris buffer (pH 8),
containing 150 mM NaCI, 0.05% Tween 20 and 5% skim milk
powder, and then for one hour at room temperature with 244
Fig. 1. DNase I Jbotprinting assays of the 5'-proximal region of the human renin gene (—336 to + 16) with human kidney cortex nuclear extracts. A. From
+ 11 to - 160 nucleotides. B. From —180 to —364 nuclcotides. Lanes I to 3 represent reactions performed without nuclear extracts —)J hut with
0.1 U, 0.05 U and 0025 U of DNase 1; lanes 4 to 6 represent reaction performed with 30 jig nuclear extracts [NE(+)] and decreasing amounts of DNase
1(1 U, 0.5 U and 0.25 U). Protected regions are indicated on the right of the figure. Panel C shows the sequences of the DNase I protected regions
of the human renin promoter in the presence of human kidney cortex cell extract. C, T, A and G are the sequencing ladder.
Table 1. Sequences of the oligonueleotides used for EMSA
Ets consensus GGAW OGAW
Ets-REN —34 CACTGTATAAAAGGGGAAGGGCTAAGGGAGCCACAG
Ets-Mi GAGTOTATAAAAGG TTGACGGCTAAGGGAGCCACAG
Ets-M2 GAGTCTATAAAP.GGGGAAGGGCTAAGTTGCCACAG
Pit.! consensus ATGNATAAWT
Pit-i .REN —88 CACGOTAATAAATCAGGGCAGAGCAGAATTGCA.AT
Pit-1-M! CACGOCGGCAAATCAGCGCAGAGCACAATTGCAAT
Pit-1-M2 CAGGGTAATGGCAGCGCAGAGCAGAATTGCAAT
Element C —!!6 GAGATTTATTGCTOACTGCCCTGCCATCTACCCCAG —80
CRE TGACGTCA
CRE-REN —235 GAGGGCTGCTAGCGTCACTGGACACAAGATTGCTTT —199
CRE-SOM —68 CTGGGGGCGCCTCCTTGGCTGACGTCAGAGAGAGAG —32
CRE-MUT GAGGGCTCCTAG TCGGAOTGGACACAAGATTGCTTT
ARP1 AGGGGTCANAGGGNTCA
ARPIREN —264 GCTCCAGGGGTCACAGGGCCAAGCCAGATAGAGGGC —228
ARPIMUT GCTCCAGGGCAGGGGTCCCGGGT1AGATAGAGGGC
AGE3 AGCTGTGCTTGT
AGE3-REN —299 CCCTGAGCAGTGCTGTTTCTCATCAOCCTCTGC —266
AGE3-MUT CCCTCGTTGATGCQ0TTTCTCATCAGCCTCTGC
Bold face letters in renin sequence indicate homologies with the
consensus sequence. W = A + T, N = 0 + A + T + C.
centrifugation, and resuspended in 400 jil of a buffer containing
20 mist Tris-HC1, pH 7.4, 0.4 M KCI, 2 mist DTT, 10% glycerol.
They were broken by freezing and thawing (3X), cell debris were
removed by centrifugation (800 g for 10 mm) at 4°C, and the
supernatant (whole cell extract) was aliquoted and stored at
—70°C.
DNase I footprinting assays
DNase I footprint analysis was performed as previously de-
scribed [31 The —336 to +16 fragment of the human renin gene
promoter was inserted in Bluescript. The synthetic DNA fragment
corresponding to —336 to + 16 was obtained by PCR amplification
using the Bluescript SK and KS universal primers. The SK or KS
32primer were labeled with [y- PIATP and T4 polynucleotide
kinase before PCR amplification. Footprint analysis was per-
formed in a 10 jil reaction mixture containing 4 mist MgCI2 4 mM
spermidine, 10 mist Hepes (pH 7.9), 50 mist KCI, 0.1 mist EDTA,
0.1 mM EGTA, 2.5% glycerol, 0.5 jig of double-stranded poly(dl-
dC), 30 jig of nuclear extract, and 15,000 cpm of end-labeled
fragment. Samples were incubated for 20 minutes at 4°C, and
digested with 2 jil DNase I (Boehringer Mannheim, 10 lU/mi;
various dilutions) for one minute at 20°C. The reaction was
stopped by adding 30 jil stop solution (50 mist EDTA, 0.1% SDS,
0.2 mg/mI yeast tRNA, and 10 mg/mI proteinase K) and incubated
for 45 minutes at 42°C. DNA was extracted once with phenol/
chloroform, precipitated with 2 volumes of ethanol, resuspended
in 98% formamide dye and electrophoresed on a 6% acrylamide/7
M urea sequencing gel.
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-364 GGGGITGGGTCTGGGCTAGGGAGCTGGAAACCTAGGTmACGC1-TGTCCCAGTT-1-1-GAT
AGE3 A9P-1
-304 GTTAGCCCTGGCAGTGcTG1TrCTCATCAGCqrCTGCCTGCTCqAGGGGTCACAGGGCq
-244 AAGCCAGATAGAGGTGCTAG9CACTGGACACAGAUGCTT-TCCCACAGCTGTCCT
- I 84 TCCTCCAGCCCCTCTGCTCCCCATCCGGAAACCTGGGTACCCUCACCCACCTAGCTCTG
-124
-64 CAGAGCAGAAUGCAATCACCCCATGCATGGAGTqTATAAAAGGGGGGGCTAAGGGp
-4 CCACAGAACCTCAGTGGATC
+1
S • •S • S
— —
—a
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antiserum (diluted 1:250; provided by Dr. M. Montminy, La Jolla,
CA, USA). The 244 antiserum was raised against a synthetic
peptide 126- 162 of the CREB protein 1181. The subsequent steps
were carried out with the biotin-streptavidin kit (Biorad), as
recommended by the manufacturer.
Results
Extracts - Renal cortex
Competitor - Element C CRE-REN
I I I I0 0 0 0
Li) 0 Li) 0
x >< x x
Footprint analysis of the human renin promoter using nuclear
extracts of kidney cortex cells
The similarity between the renal cortex and chorionic cell
binding proteins was examined by the DNase I footprinting assay,
using human kidney cortex cell nuclear extracts and the promoter
sequence spanning —336 to +16. The same six protected regions
found in human chorionic cell nuclear extracts [3] were identified
(Fig. 1). The first footprint comprised sequences from —29 to —6
and contained a central purine rich sequence (GGAA) that is a
conserved recognition site for Ets-domain proteins [4]. The
second footprint (—77 to —63) was similar to the Pit-I binding site
consensus sequence (ATGNATAAWT) [5]. The third footprint
(—123 to —86) was not homologous to any described regulatory
elements. The fourth footprint (—229 to —209) was very similar
to the CRE (TGACGTCA) [6]. The footprint 5 (—259 to —245)
was similar to the binding site for ARP-1 (AGGGGT-
CAAGGGNTCA) [71. Footprint 6 (—294 to —272) was very
similar (75%) to the sequence AGE3 (AGCTGTGCTTGT) de-
scribed by Tamura et al [81 in the human angiotensinogen gene.
The specificity of the interactions between the nuclear proteins
and the binding sites determined by footprint analysis were
assessed by EMSAs using the oligonucleotides listed in Table 1.
Binding of renal cortex nuclear extracts at the C element of the
human renin promoter
The binding of renal cortex proteins to the human renin
promoter element C was measured by EMSA using a double-
stranded oligonucleotide element C (—116 to —80) as the probe.
One of the two DNA/protein complexes revealed was specific, as
shown by competition experiments using excess homologous
unlabeled DNA (Element C); even a 100-fold excess did not
compete for the entire binding. Formation of this complex was not
blocked by non-specific unlabeled DNA (CRE-REN) (Fig. 2).
These results suggest that renal protein(s) form a specific complex
with the human renin sequence corresponding to the element C.
Binding of renal cortex nuclear extracts at the AGE3-like sequence
in the human renin promoter
The binding of renal cortex proteins to the AGE3-like region in
the human renin promoter was examined by EMSA using a
labeled double-stranded oligonucleotide AGE3-REN (—299 to
—266) containing the renin AGE3-like sequence as probe. One
specific DNA/protein complex was formed, and its formation was
completely blocked by the homologous unlabeled probe (AGE3-
REN). But the complex was still formed in the presence of box
excess of unlabeled probe (AGE3-MUT) (Fig. 3). Thus, the
AGE3-like sequence of the human renin promoter may form a
specific complex with renal proteins.
Fig. 2. Electromobility shift assay of human kidney cortex nuclear extracts
with the human renin promoter (Element C: —116 GAGA TTTA TTGCT-
GACTGCCCTGCCATCTACCCCAG -80). A double-stranded oligonucle-
otide containing element C was used as the probe. Competitions were
performed with homologous DNA (Element C) or with non-specific compet-
itor oligonucleotide (CRE-REN: —234 GAGATVI7AfF(KTGAD'GC-
CCTGCCATCTACCCCAG -80). Arrow indicates the specific DNA/pro-
tein complex. The molar excess (x-fold) of each competitor sequence is
indicated.
The renal proteins binding to the human renin CRE and Pit-I-like
motif
Two specific high affinity DNA/protein complexes are formed
between the CRE-REN and the proteins in kidney extracts [9].
These two complexes, similar to those observed with chorionic cell
nuclear extracts [31 represent sequence-specific interactions, as
shown by competition experiments using excess unlabeled CRE-
REN.
Supershift experiments [91 using anti-CREB serum 244 dem-
onstrated that CREB from renal and chorionic cells binds to the
'S
Extracts
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Fig. 4. Western blot analysis of human chorionic cell and kidney cortex
nuclear extracts. The samples applied are shown at the top; 25 ng purified
CREB (lane 1), 2 pg and I pg of kidney cortex (lanes 2 and 3) and 1, 0.5
and 0.25 pg of chorionic cells (lanes 4 to 6) nuclear extracts are also
indicated. Molecular weight of standard proteins are indicated in each
margin. CREB antiserum 244 was used diluted 1:250.
Fig. 3. Electromobility shift assay of human kidney cortex nuclear extracts
with the human renin promoter (AGE3-REN: —299 CCCTGAGCAGT-
GCTGTTTCTAT(/AGCCTCTGC --266). A double-stranded oligonu-
cleotide containing the renin AGE3-like site (AGE3-REN) was used as
the probe. Competitions were performed with homologous DNA (AGE3-
REN), or with a mutated consensus site oligonucleotide (AGE3-MUT:
-299 CCCTGGTTGATGCGITI'CTCATCAGCCTCTGC -266). Arrow
indicates the specific DNA/protein complex. The molar excess of of each
competitor sequence is indicated.
CGTCA element of the human renin promoter. Western blot
analyses were carried out to identify the protein binding to the
human renin CRE (Fig. 4). The major kidney cortex or chorionic
cell proteins revealed by the anti-CREB serum, had the same
molecular weight (42 kDa) as purified CREB. The other bands
revealed with higher concentrations of nuclear extracts were
nonspecific binding of the antibody raised against a synthetic
peptide. This result, combined with EMSA competition experi-
ments, indicates that CREB binds to the CGTCA element of the
human renin gene promoter.
Previous EMSAs with kidney cortex nuclear extracts and a
labeled oligonucleotide (—88 to —54) corresponding to the renin
Pit-I site (Pit-1-REN) showed two specific DNA/protein com-
plexes [91. Two mutations were used to test whether the nucleo-
tides known to be important in the Pit-i consensus binding site
were involved in the formation of the complexes. Mutation of the
Pit-1-REN oligonucleotide to Pit-i-Mi (which corresponds to the
Pit-i-1 of [91) eliminates its ability to compete for the DNA!
protein complexes obtained with Pit-i-REN (Fig. 5). The same
results were obtained with mutation of the other part of Pit-i
consensus binding site (Pit-1-M2; Fig. 5). This second mutation
has been already described by Sun et al [19], who found compe-
tition using GC cell extracts. Our studies with renal nuclear
extracts showed that the entire motif TAATAAATCAG of the
Pit-i consensus sequence in the human renin promoter is neces-
sary for binding.
Binding of kidney cortex cell nuclear extracts to the Ets protein
recognition site of the human renin promoter
The renal proteins binding to the human renin Ets site were
identified by EMSA using a labeled double-stranded oligonucle-
otide Ets-REN (—34 to +12) corresponding to the renin Ets site.
Two specific high-affinity DNA/protein complexes were formed,
and their formation could be blocked by excess homologous
unlabeled Ets-REN. The DNA sequence involved in binding was
identified by competition experiments with mutated Ets binding
site oligonucleotides (Ets-Mi and Ets-M2). Ets-REN contains
two GGA, one of which were changed to ITO in Ets-MI and the
other in Ets-M2 oligonucleotides (Table 1). As shown in Figure 6,
50- to 200-fold molar excesses unlabeled Ets-Mi or Ets-M2 did
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Fig. 5. Electromobilily shift assay of human kidney cortex nuclear extracts with the human renin promoter 'Pit-1-REN: —88 cAGGGTAATAAAT-
CAGGGCAGAGCAGAATTGCAAT —54). A double-stranded oligonucleotide containing the renin Pit-i binding consensus site (Pit-1-REN) was used
as the probe. Competitions were performed with homologous DNA (Pit-1-REN) or with mutated consensus site oligonucleotides (Pit-i-Mi: —88
CAGGGCGGCAAATCAGGGCAGAGCAGAATTGCAAT -54 and Pit-i -M2: -54 CAGGGTAATGGGCCAGGGCAGAGCAGAATFGCAAT
—54). Arrows indicate the specific DNA/protein complexes. The molar excess of each competitor sequence is indicated.
not block the complex formation, showing that the two GGA are
involved in binding to the human renin promoter.
EMSAs were also run using the same labeled double-stranded
oligonucleotide (Ets-REN) plus Ets-1 transfected Cos-1 cell ex-
tracts (Fig. 6). The same specific DNA/protein complexes were
observed, and their formation was blocked by homologous probe,
but not by the two mutated oligonucleotides (Ets-MI and Ets-
M2). Thus, these two DNA/protein complexes are specific for the
renin Ets-1 domain protein recognition site-like sequence, as
mutation of each GGA did not prevent binding. Comparison of
the two EMSA experiments also suggests that renal cortex
extracts contain Ets-1 protein(s), which bind(s) to the human
renin promoter.
Binding of kidney cortex cell nuclear extracts to the ARP-1 binding
consensus site of human renin promoter
The renal proteins binding to the human renin ARP-l site, were
identified by EMSA using a labeled double-stranded oligonucle-
otide ARP-1-REN (—264 to —228). One specific DNA/protein
complex was formed, which was competitively inhibited by excess
unlabeled homologous probe, ARP-1-REN (Fig. 7). The specific-
ity of binding was examined in experiments using the double-
stranded oligonucleotide ARP-1-MUT, corresponding to the mu-
tation of ARP-i binding site and with CRE-REN, as non-
homologous probe. Neither probe prevented complex formation
(Fig. 7).
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Fig. 6. Electromobility shift assay of Ets-]
transfected Cos-1 cell extracts and human kidney
cortex nuclear extracts with the human renin
promoter (—34 to +2). A double-stranded
oligonucleotide containing the renin Ets protein
recognition site like region (Ets-REN: —34 GA-
GTGTATAAAAGGGGAAGGGCTAAGGGA-
GCCACAG +2) was used as the probe.
Competitions were performed with homologous
DNA (Ets-REN) or with mutated consensus
site oligonucleotides (Ets-Mi: —34 GAGTGTA-
TAAAGGTTGAGGGCTAAGGGAGCCAC-
AG +2 and Ets-M2: -34 GAGTGTATAAAA-
GGGGAAGGGCTAAGTTGGCCACAG +2).
Arrows indicate the specific DNA/protein
complexes. The molar excess of each
competitor sequence is indicated.
Lastly, EMSA was performed using the labeled double-
stranded oligonucleotide (ARP-1-REN) with ARP-1 transfected
Cos-1 cell extracts. The same specific DNA/protein complex was
found, and its formation was blocked by the homologous probe,
but not by the oligonucleotides, ARP-1-MUT and CRE-REN
(Fig. 7). Hence, the DNA/protein complex observed with EMSA
is a specific interaction between the ARP-1 binding site like-
sequence in the human renin promoter and renal proteins.
Discussion
The nuclear proteins binding the human renin promoter have
not yet been examined using human JG cells because no suitable
culture model is available. Due to the very low capacity of
division, the only human JG cell line previously published [201 is
not suitable to perform the present studies. Cells derived from
human chorion tissue have been used to study renin gene tran-
scription despite the fact they are of extra-renal origin. Recent
studies demonstrate that human chorionic cells are suitable for
studying the transcriptional regulatory elements in renin gene
expression [3]. This model was also used to demonstrate that the
CRE and Pit-i consensus sites are implicated in the regulation of
rcnin gene transcription by cAMP [9]. However, it was necessary
to determine whether that transcription factors in the kidney,
which is the main site of renin synthesis, bind to the renin
promoter elements identified using chorionic cells. Ischemic
human kidneys removed because of renovascular hypertension
are considerably enriched in renin [211. Cortex cell nuclear
extracts were prepared from these kidneys although the cell
population is heterogeneous. These kidneys were chosen for their
high renin content (between 0.5 to 15 jxg/g of tissue) compared to
normal kidneys (1.6 ng/g of tissue). The limited number of JG
cells in the cortex (less than 1/100,000 of renal cells) prevented the
preparation of JG cell nuclear extracts, and proteins from other
renal cells (endothelial, mesangial, proximal tubular, distal cells,
etc.) may have bound to the human renin promoter.
The overall goal of this study was to identify the cis-regulatory
elements and trans-activating factors involved in the expression of
the human renin gene using human kidney cortex nuclear extracts.
The first step was to determine whether the same transcription
factors from human chorionic cells and kidney cortex cells bind to
the human renin proximal promoter. The renin promoter se-
quence spanning —336 to + 16 was subjected to DNase I footprint
analysis and showed the same six footprints as with chorionic cell
nuclear extracts [3]. These putative cis-elements consist of an
• esa ca •I s_ •
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Fig. 7. Electromobilily shift assay of ARP-1
transfected Cos-1 cell extracts and human kidney
cortex nuclear extracts with the human renin
promoter (—264 to —228). A double-stranded
labeled oligonucleotide containing the renin
ARP-1 binding site-like region (ARP-1-REN:
-264 GCTCCAGGGGTCACAGGGCCAAGC-
CAGATAGAGGGC -228) was used as the
probe. Competitions were performed with
homologous DNA (ARP-1-REN), with a
mutated consensus site oligonucleotide (ARP-1-
MUT: -264 GCrCCAGGGCAGGGGTCCCGGG-
TFCAGATAGAGGGC -228) or with a non-
specific oligonucleotide (CRE-REN: 1—235 GA-
GGGCITG(ITAGCGTCACTGGACACAAGAT-
TGCFTT —199). Arrow indicates the specific
DNA/protein complex. The molar excess of each
competitor sequence is indicated.
Ets-domain protein (—291—6) [4], a Pit-i-like binding site (—79/
—62) [5], a CRE sequence (—2341—214) [6], an ARP-l like
binding site (—2591—245) [7], an AGE3 like region (—293/—272)
[81, and an unknown region (— 107/—83), designated element C.
This study shows that nuclear proteins from the human kidney
cortex hind to the human renin proximal promoter. The same
sequences on the human renin promoter bind factors from both
chorionic cells and human kidney cells.
The proteins and their binding to the human renin promoter
were characterized by EMSAs and the consensus site was deter-
mined by footprint analysis. The DNA sequence corresponding to
the element C footprint is unlike any previously described regu-
latoTy element consensus sequence. Renal cortex nuclear extracts
formed a complex with the element C sequence, hut as no
function for element C was found in chorionic cells [3], the
nucleotides binding kidney proteins were not examined further.
Footprint 6 (—294 to —272) is very similar to a sequence of the
mouse angiotensinogen gene that binds the constitutive factor,
AGF-3 [8]. This factor could play an important role in the
differentiation-dependent promoter activation of the mouse an-
giotensinogen gene in adipocytes [22]. We have used transient
DNA transfections of various renin/luciferase constructs in cho-
rionic cells to demonstrate that an "AGF3-like" protein negatively
regulates renin gene expression [3]. The present EMSA studies
show that renal cortex nuclear proteins hind to this region. The
same factor may interact with the renin and angiotensinogen gene
promoters to regulate their expression reciprocally and hence play
an important role in regulating the entire renin-angiotensin
system.
Ets domain proteins are proto-oncogenes and transcription
activators [14, 23—261. We have shown that the first 67 bp of the
renin promoter are sufficient to direct expression in chorionic cells
[31. This study now shows that renal cortex nuclear proteins bind
to this region and that both GGA nucleotides are important for
the interactions. Thus, Ets-1 from both chorionie and renal cells
hinds to the human renin gene promoter and positively regulates
renin gene expression
Our recent transient DNA transfection studies using chorionic
Extracts Renal cortex
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cells show that full activation of renin gene transcription by cAMP
is due to interactions of trans-activating factors with the two
binding sequences, the CRE and the Pit-I motif [9]. We showed
that the migration patterns of the DNA/protein interactions with
chorionic and kidney cortex cell extracts are similar, indicating
that the CGTCA sequence motif is essential for the binding, as
described by Fink et al [27]. The present study confirms the
presence of immunoreactive CREB with the same molecular
weight (42 kDa) in both extracts. Both renal and chorionic CREB
binds to the CRE element of the human renin promoter and play
a role in renin regulation by cAMP.
Pit-i is a member of the POU family of transcription factor that
influence the proliferation of certain cells and their expression of
specific genes [28]. A Pit-I binding motif is involved in the
regulation of the human rerun gene in GC cells by cAMP [19] and
in human chorionic cell [9]. Tamura et al [29, 30] demonstrated
that a nuclear factor in the Pit-I deficient cell line, the human
embryonal kidney 293 cell, interacts with the RP-2 element whose
sequence is very similar to the Pit-i binding site [31]. We have
shown that distinct nuclear proteins from both kidney cells and
chorionic cells specifically bind to the renin Pit-i element [9], and
that by several EMSA experiments the protein binding to this site
is not Pit-i. The present results show that all the DNA sequence
TAATAAAT is needed for binding of renal proteins, unlike the
finding of Sun et al [19] for GC cells, who show that only the
second part of the Pit-i consensus sequence is required.
ARP-1 protein is a member of the orphan steroid receptor
superfamily that inhibits expression of the apoAl gene [7]. Our
previous DNA transfection experiments using chorionic cells
suggested that the ARP-1 binding site-like region of the renin
promoter negatively regulates reniri gene expression [3]. The
present study indicates that renal proteins interacts specifically
with the ARP-1 binding site. The same complex was formed with
enriched ARP-1 nuclear extracts. In contrast to the findings of
Horiuchi et al [32] with mouse kidney extracts, the interaction was
not blocked by an oligonucleotide containing the renin CRE
(CRE-REN). This could be due to the different species of DNA
involved. Our results suggest that renal cortex extracts contain
ARP-i protein(s) that bind(s) to the human renin promoter.
In conclusion, human renal cortex proteins interact with six
putative cis-elements of the human renin promoter. One of them
is CREB, two others seem to be Ets-1 and ARP-1, and one binds
the Pit-i-like motif, but it is different from Pit-I. Thus the human
renal cortex and chorionic cells both contain the same factors that
bind to the proximal human renin promoter, showing that the
chorionic cell line is a suitable model for studying the functionality
of the human renin promoter. Some of transcription factors
described may be implicated in the tissue-specific expression of
renin and in the regulation of its production in vivo.
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Appendix
The abbreviations used in this study are: Pit-I, pituitary-specific trans-
acting factor; CRE, cAMP response element; CREB, cAMP response
element binding protein; ARP-1, apoAl regulatory protein-i; EMSA,
electromobility shift assay.
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